2018 AAO Retina Sub-Day: New Surgical Instruments
Eric Nudleman, MD, PhD UC San Diego, Shiley Eye Institute RETINA Roundup Co-Editor An annual ritual at the AAO subspeciality day includes a rapid tour of the newest instrument and…
Category: Meeting Coverage
2018 AAO Retina Sub-Day: Surgical Complications Session
Kotaro Tsuboi, MD Assistant Professor of Ophthalmology Motohiro Kamei, MD, PhD Professor and Chair of Ophthalmology Aichi Medical University Nagoya, Japan The “Video Surgical Complications-What Would You Do?” session was…
2018 AAO Uveitis Sub-Day: Suprachoroidal Delivery of CLS-TA for Uveitic Macular Edema
Dilraj Grewal, MD Associate Professor of Ophthalmology Duke Eye Center The Uveitis Subspecialty day Avant-Garde Blues session included late breaking talks on uveitis trials. Suprachoroidal Delivery of CLS-TA for Uveitic…
2018 AAO Retina Subday: Simultaneous Inhibition of VEGF and Ang-2 with Genentech’s Faricimab in Neovascular AMD: STAIRWAY Phase 2 Results
Brian K. Do, MD The Retina Group of Washington Dr. Arshad Khanani, MD, of Sierra Eye Associates, in Reno, NV, presented these promising phase 2 data in one of the…
2018 AAO Retina Subday: Pediatric Retina
Lauren Wright, MD Vitreoretinal Surgery Fellow Boston University The 2018 AAO Sub-Specialty day highlighted an exciting assortment of hot topics in the field of Pediatric Retina. On day one of…
2018 AAO Retina Subday: Vitreoretinal Surgery
Brian K. Do, MD The Retina Group of Washington The second session of 2018’s Retina Subspecialty Day, moderated by Maria H. Berrocal, MD, and John W. Kitchens, MD, introduced a…
2018 AAO Retina Subday: The Art and Science of YAG Vitreolysis
Rithwick Rajagopal, MD, PhD Washington University School of Medicine Symptomatic floaters are a common source for frustration for both patients and vitreoretinal surgeons. As care providers, we are committed to…
2018 AAO Retina Subday: First-Time Phase II Results of Brimo-DDS for Geographic Atrophy
Cynthia X. Qian, MD Assistant Professor of Ophthalmology University of Montreal The “First-Time Results of Clinical Trials” session had two presentations from Allergan trials. The first talk introduced the Phase…